Industry News (Joint Venture)

Strategic Alliance Formed To Further Improve Blood Safety

Published in Hepatitis Weekly, July 27th, 1998

Chiron Corp., Emeryville, California, and Gen-Probe Inc. announced that the two companies have signed an agreement to form a strategic alliance to develop, manufacture and market nucleic acid probe assay systems for blood screening and certain areas of diagnostics.

Under the terms of the agreement, Chiron markets and sells products that utilize Chiron's intellectual property relating to hepatitis C (HCV) and HIV and Gen-Probe's patented transcription-mediated amplification (TMA), target capture, hybridization protection assay (HPA) and dual kinetic assay (DKA) technologies.

Gen-Probe is scheduled to complete, in 1998, the development of the first...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (1998-07-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry